The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Dr. Siegel discusses CDPATH, which uses a blood test to evaluate an adult patient’s potential risk within 3 years of developing bowel strictures, internal penetrating disease, or non-perianal surgery (bowel resection or stricturoplasty). Used with physician’s assessment, CDPATH can help facilitate shared decision-making (U.S. availability; no cost to eligible patients).
This Product Theater is sponsored by Takeda and is not affiliated with AGA.
Speaker(s):
Corey
Siegel,
MD, MS,
Dartmouth-Hitchcock Medical Center
You must be logged in and own this session in order to
post comments.